Explore more Johnson & Johnson sites:
Share
Back to top
Health & Wellness
-
It’s estimated that over 300 million people around the globe are living with a rare disease.
-
The common circulatory condition is a leading cause of amputations in the U.S. Learn why Black Americans are disproportionately affected and how Johnson & Johnson is helping to raise awareness about the disease.
-
The goal to eliminate prostate cancer starts with getting people to talk about it—especially Black men, who are two times more likely to die from the disease than most other men. Here's what a physician says about building awareness and normalizing tough conversations.
-
When Craig was diagnosed with multiple myeloma, his wife Cara took on a new role: caregiver. Here, she shares the challenges—as well as the triumphs—of this difficult journey.
-
For World Health Day, learn how Johnson & Johnson’s commitment to Diversity, Equity and Inclusion is helping to deliver transformational cancer treatments and solutions that reach the patients who need them most.
-
Improvements in joint replacement techniques and technology have increased the effectiveness of this common procedure—yet some hip replacements still require a revision. Learn the latest about the surgery, plus how Johnson & Johnson is innovating to change this stat.
-
More and more, many previously effective medications are no longer able to fight off the germs that are making us sick, leading to millions of deaths each year. For World Antimicrobial Awareness Week, learn what Johnson & Johnson is doing to combat this health threat around the world.
-
More than 200 million people worldwide are living with an autoantibody disease, which occurs when the body attacks its own cells, tissues and proteins.
-
For Pregnancy and Infant Loss Awareness Month, learn how one woman advocated for herself and fought to complete her family after she was diagnosed with hemolytic disease of the fetus and newborn—and why Johnson & Johnson is committed to finding a better treatment for this rare and deadly blood disorder.
-
From cultural stigma to language barriers, getting necessary treatment can be challenging for these groups. For Hispanic Heritage Month, learn more about what the company is doing to help people surmount unique obstacles to get the resources they need.
-
Johnson & Johnson's Brian Woodfall, M.D., was working at a Vancouver clinic in the mid-1990s. That's where he met Tiko Kerr, who became one of the first patients to take the company's HIV medicines—and has thrived to this day. For National AIDS Awareness Month, watch as Kerr, Dr. Woodfall and fellow researcher Joss J. De Wet, M.D., reflect on how those treatments have saved lives and continue to evolve, in this moving video.
-
Two new Johnson & Johnson initiatives aim to remove the obstacles people of color and the LGBTQIA+ community have historically faced in getting help with mental illness. The head of Janssen Neuroscience, Courtney Billington, explains why breaking these barriers is a priority—and a personal mission.
-
Imagine if you were trying to speak and no one could understand you. That's what it's like to live with this language-impairing condition. For National Aphasia Awareness Month, learn how to spot the symptoms of the neurological disorder and what to do if you're afflicted.
-
For Pride Month, Lynn Discenza shares her transition journey and how gender-affirmation surgery helped her reclaim her confidence and be who she's always wanted to be. Plus, learn how Johnson & Johnson MedTech is working to help ensure more people have access to the life-changing procedure.
-
As global temperatures continue to rise, so too does the incidence of this mosquito-borne virus. For World NTD Day, learn the latest about this growing health threat and how Johnson & Johnson is working to combat it.
